InsidersTradesSigma
Follow the 케어랩스 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 케어랩스 has published 5 insider filings. Market capitalisation: €33.1bn. The latest transaction was reported on 9 July 2026 (Purchase). Among the most active insiders: 원익홀딩스. The full history is openly available.
5
Insider Decl.
n/a
Thresholds
n/a
4 ops.
Buy Volume
n/a
n/a
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,936 of 29,056 companies
71.0
score / 100
Value68
Quality74
FCF yld-41%
Earn yld51%
EV/EBITDA1.5x
ROE-7.1%
Gross mgn98%
Net mgn23%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 July 2026
Acerca de 케어랩스
Carelabs es una empresa especializada en el sector de la salud y farmacéutico. Cotiza en el mercado XKRX.